News on Takeda Pharmaceutical Company Limited from BioPortfolio.com http://www.BioPortfolio.com Consolidated Takeda Pharmaceutical Company Limited news from BioPortfolio.com Wed, 10 Feb 2010 00:23:32 GMT en Broad Intelligence International Pharmaceutical Holdings Limited.-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034211&HITNO=0&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034211&THISHREF=http://c.moreover.com/click/here.pl%3fz2535681675%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034211&HITNO=0&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034211&THISHREF=http://c.moreover.com/click/here.pl%3fz2535681675%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Bukwang Pharmaceutical Company Limited-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034154&HITNO=1&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034154&THISHREF=http://c.moreover.com/click/here.pl%3fz2535666691%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034154&HITNO=1&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034154&THISHREF=http://c.moreover.com/click/here.pl%3fz2535666691%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Brookes Pharmaceutical Laboratories (Pakistan) Limited-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034158&HITNO=2&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034158&THISHREF=http://c.moreover.com/click/here.pl%3fz2535671318%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034158&HITNO=2&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034158&THISHREF=http://c.moreover.com/click/here.pl%3fz2535671318%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: C&O Pharmaceutical Technology (Holdings) Limited-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034134&HITNO=3&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034134&THISHREF=http://c.moreover.com/click/here.pl%3fz2535652270%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034134&HITNO=3&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034134&THISHREF=http://c.moreover.com/click/here.pl%3fz2535652270%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: China Shineway Pharmaceutical Group Limited-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033749&HITNO=4&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033749&THISHREF=http://c.moreover.com/click/here.pl%3fz2535380508%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033749&HITNO=4&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033749&THISHREF=http://c.moreover.com/click/here.pl%3fz2535380508%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Seattle Genetics Reports Fourth Quarter and Year 2009 Financial Results and Provides 2010 Financial Outlookhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038347&HITNO=5&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038347&THISHREF=http://c.moreover.com/click/here.pl%3fz2537573233%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038347&HITNO=5&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038347&THISHREF=http://c.moreover.com/click/here.pl%3fz2537573233%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Seattle Genetics Reports Fourth Quarter and Year 2009 Financial Results and Provides 2010 Financial Outlookhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038334&HITNO=6&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038334&THISHREF=http://c.moreover.com/click/here.pl%3fz2537570069%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038334&HITNO=6&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038334&THISHREF=http://c.moreover.com/click/here.pl%3fz2537570069%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Seattle Genetics Reports Fourth Quarter and Year 2009 Financial Results and Provides 2010 Financial Outlookhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038324&HITNO=7&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038324&THISHREF=http://c.moreover.com/click/here.pl%3fz2537567263%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038324&HITNO=7&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038324&THISHREF=http://c.moreover.com/click/here.pl%3fz2537567263%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Seattle Genetics Reports Fourth Quarter and Year 2009 Financial Results and Provides 2010 Financial Outlookhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038092&HITNO=8&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038092&THISHREF=http://c.moreover.com/click/here.pl%3fz2537470218%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038092&HITNO=8&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038092&THISHREF=http://c.moreover.com/click/here.pl%3fz2537470218%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Seattle Genetics Reports Fourth Quarter and Year 2009 Financial Results and Provides 2010 Financial Outlookhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038009&HITNO=9&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038009&THISHREF=http://c.moreover.com/click/here.pl%3fz2537428129%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038009&HITNO=9&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038009&THISHREF=http://c.moreover.com/click/here.pl%3fz2537428129%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Seattle Genetics Reports Fourth Quarter and Year 2009 Financial Results and Provides 2010 Financial Outlookhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037880&HITNO=10&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037880&THISHREF=http://c.moreover.com/click/here.pl%3fz2537350398%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037880&HITNO=10&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037880&THISHREF=http://c.moreover.com/click/here.pl%3fz2537350398%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire via Yahoo!: Seattle Genetics Reports Fourth Quarter and Year 2009 Financial Results and Provides 2010 Financial Outlookhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037874&HITNO=11&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037874&THISHREF=http://c.moreover.com/click/here.pl%3fz2537348238%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037874&HITNO=11&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037874&THISHREF=http://c.moreover.com/click/here.pl%3fz2537348238%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: Seattle Genetics and Millennium Announce Initiation of Phase I Combination Clinical Trial of Brentuximab Vedothttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036670&HITNO=12&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036670&THISHREF=http://c.moreover.com/click/here.pl%3fz2536700451%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036670&HITNO=12&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036670&THISHREF=http://c.moreover.com/click/here.pl%3fz2536700451%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAmerican Pharmaceutical Outsourcing: Takeda launches osteosarcoma medicine Mepact in EUhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028620&HITNO=13&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028620&THISHREF=http://c.moreover.com/click/here.pl%3fz2532788228%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028620&HITNO=13&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028620&THISHREF=http://c.moreover.com/click/here.pl%3fz2532788228%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Extrawell Pharmaceutical Holdings Limited-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029848&HITNO=14&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029848&THISHREF=http://c.moreover.com/click/here.pl%3fz2533299927%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029848&HITNO=14&MSIZE=432&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceutical%20Company%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029848&THISHREF=http://c.moreover.com/click/here.pl%3fz2533299927%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: